ioversol has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brancatelli, G | 1 |
| Baron, RL | 1 |
| Federle, MP | 1 |
| Sparacia, G | 1 |
| Pealer, K | 1 |
| Ng, CS | 1 |
| Charnsangavej, C | 1 |
| Wei, W | 1 |
| Yao, JC | 1 |
| Park, JH | 1 |
| Nazarian, LN | 1 |
| Halpern, EJ | 1 |
| Feld, RI | 1 |
| Lev-Toaff, AS | 1 |
| Parker, L | 1 |
| Wechsler, RJ | 1 |
1 trial available for ioversol and Disease Exacerbation
| Article | Year |
|---|---|
Perfusion CT findings in patients with metastatic carcinoid tumors undergoing bevacizumab and interferon therapy.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bev | 2011 |
2 other studies available for ioversol and Disease Exacerbation
| Article | Year |
|---|---|
Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT.
Topics: Adult; Aged; Contrast Media; Disease Progression; Female; Humans; Iothalamate Meglumine; Linear Mode | 2009 |
Comparison of unenhanced and contrast-enhanced spiral CT for assessing interval change in patients with colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Disease Progression; Female; Humans; Iothalamate | 2001 |